These results indicate that sesamin cooperatively downregulates MMP-2, p-JNK1/2, and P-p38 and inhibits the MAPK signaling pathway along with p38 and p-JNK inhibitors in oral cancer cells. The gene discussed is MMP2; the disease is lip and oral cavity carcinoma.